WARSAW, Ind., Aug. 26, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a worldwide medical expertise chief, as we speak introduced that its Board of Administrators has accredited the fee of a quarterly money dividend to stockholders for the third quarter of 2022. The money dividend of $0.24 per share is payable on or about October 31, 2022 to stockholders of report as of the shut of enterprise on September 30, 2022.

Concerning the Firm
Zimmer Biomet is a worldwide medical expertise chief with a complete portfolio designed to maximise mobility and enhance well being. We seamlessly remodel the affected person expertise by way of our modern merchandise and suite of built-in digital and robotic applied sciences that leverage knowledge, knowledge analytics and synthetic intelligence.  

With 90+ years of trusted management and confirmed experience, Zimmer Biomet is positioned to ship the best high quality options to sufferers and suppliers. Our legacy continues to return to life as we speak by way of our progressive tradition of evolution and innovation. 

For extra details about our product portfolio, our operations in 25+ nations and gross sales in 100+ nations or about becoming a member of our crew, go to www.zimmerbiomet.com or observe Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Media                                                                              Traders
Meredith Weissman                                                      Keri Mattox
703-346-3127                                                                215-275-2431
[email protected]                 [email protected] 

SOURCE Zimmer Biomet Holdings, Inc.



Supply hyperlink

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Board of Works Approves Settlement For Heart Lake Pavilion Undertaking – InkFreeNews.com

Board of Works Approves Settlement For Heart Lake Pavilion Undertaking – InkFreeNews.com

On the Warsaw Board of Public Works and Security’s assembly on Friday, Sept. 2, Zimmer Biomet Company Social Duty Supervisor Adam Griner introduced a test for $2 million from the

Spinal Intervention Market: In-depth evaluation of the segmentation assists to find out prevailing market alternatives

Spinal Intervention Market: In-depth evaluation of the segmentation assists to find out prevailing market alternatives

Evaluation of present analysis and scientific developments is supplied with key dynamic components that assist in understanding the market habits. PORTLAND, OREGON, UNITED STATES, September 2, 2022 /EINPresswire.com/ — Spinal

Knee Implants Market – Rising prevalence of arthritis

Knee Implants Market – Rising prevalence of arthritis

Knee Implants Market 📝Overview: A knee transplant is a surgical process carried out to switch the broken bone and cartilage of the knee with a knee implant to rebuild the